MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$90,000
Net Income
-$13,432,000
Net Profit Margin
-14924.44%
Unit: Dollar
Revenue Breakdown
Product
Royalty
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
90,000
15,000
77,000
15,000
Cost of revenue
36,000
0
23,000
0
Research and development
3,471,000
329,000
5,503,000
3,513,000
General and administrative
1,930,000
1,747,000
2,046,000
2,150,000
Total operating expenses
5,437,000
2,076,000
7,572,000
5,663,000
Loss from operations
-5,347,000
-2,061,000
-7,495,000
-5,648,000
Interest income
55,000
47,000
40,000
40,000
Interest expense
695,000
791,000
746,000
649,000
Loss on extinguishment of notes payable
-
-
0*
-
Issuance costs for common stock warrant liabilities
0
393,000
0*
-
Loss on initial issuance of equity
0
-4,582,000
0*
-
Change in fair value of common stock warrant liabilities
4,132,000
1,060,000
789,000
1,728,000
Change in fair value of derivative liabilities
-3,333,000
713,000
-274,000
-797,000
Change in fair value of clene nanomedicine contingent earn-out liability
-
-
0*
0
Change in fair value of initial stockholders contingent earn-out liability
-
-
0*
0
Research and development tax credits and unrestricted grants
28,000
36,000
38,000
5,000
Other expense, net
-
-
0*
-
Total other income (expense), net
-8,077,000
-6,030,000
-1,731,000
-3,129,000
Net loss before income taxes
-13,424,000
-8,091,000
-9,226,000
-8,777,000
Income tax expense
0
0
0
0
Net loss
-13,424,000
-8,091,000
-9,226,000
-8,777,000
Unrealized loss on available-for-sale securities
-
-
0
0
Foreign currency translation adjustments
-8,000
44,000
22,000
1,000
Total other comprehensive income (loss)
-8,000
44,000
22,000
1,000
Comprehensive loss
-13,432,000
-8,047,000
-9,204,000
-8,776,000
Basic EPS
-1.08
-0.69
-0.852
-0.85
Basic Average Shares
12,382,702
11,644,214
10,802,689
10,284,674
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$13,432,000
(-82.60%↓ Y/Y)
Net loss
-$13,424,000
(-80.94%↓ Y/Y)
Total other
comprehensive income (loss)
-$8,000
(-112.70%↓ Y/Y)
Net loss before
income taxes
-$13,424,000
(-80.94%↓ Y/Y)
Foreign currency
translation adjustments
-$8,000
(-112.70%↓ Y/Y)
Product
$74,000
(7300.00%↑ Y/Y)
Royalty
$16,000
(-38.46%↓ Y/Y)
Total other income
(expense), net
-$8,077,000
(-419.42%↓ Y/Y)
Loss from operations
-$5,347,000
(8.82%↑ Y/Y)
Interest income
$55,000
(-11.29%↓ Y/Y)
Research and development
tax credits and...
$28,000
(75.00%↑ Y/Y)
Total revenue
$90,000
(233.33%↑ Y/Y)
Change in fair value of
common stock warrant...
$4,132,000
(702.33%↑ Y/Y)
Change in fair value of
derivative liabilities
-$3,333,000
(-659.23%↓ Y/Y)
Interest expense
$695,000
(2.36%↑ Y/Y)
Total operating
expenses
$5,437,000
(-7.71%↓ Y/Y)
Research and development
$3,471,000
(-1.22%↓ Y/Y)
General and
administrative
$1,930,000
(-18.81%↓ Y/Y)
Cost of revenue
$36,000
Buy us a coffee
Clene Inc. (CLNN)
Clene Inc. (CLNN)